The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan-Reference-Cited by-同舟云学术

The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan

Published:2020-04-01 Issue:4 Volume:43 Page:693-696
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ishii Saki¹,Muraki Yuichi¹,Kusama Yoshiki²,Yagi Tetsuya³,Goto Ryota¹,Ebisui Ai¹,Kawabe Ayako¹,Inose Ryo¹,Ohmagari Norio²

Affiliation:

1. Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University

2. AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine

3. Department of Infectious Diseases, Nagoya University Graduate School of Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/4/43_b19-01000/_pdf

Reference21 articles.

1. 1) Teng C, Reveles KR, Obodozie-Ofoegbu OO, Frei CR. Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA adverse event reporting system. Int. J. Med. Sci., 16, 630–635 (2019).

2. 2) Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010–2014. Am. J. Infect. Control, 45, 964–968 (2017).

3. 3) King A, Mullish BH, Williams HRT, Aylin P. Comparative epidemiology of Clostridium difficile infection: England and the USA. Int. J. Qual. Health Care, 29, 785–791 (2017).

4. 4) Pearson A. Historical and changing epidemiology of healthcare-associated infections. J. Hosp. Infect., 73, 296–304 (2009).

5. 5) Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med., 372, 825–834 (2015).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent development of small-molecular inhibitors against Clostridioides difficile infection;Bioorganic Chemistry;2022-08

2. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan;Journal of Infection and Chemotherapy;2022-02

3. An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan;Journal of Infection and Chemotherapy;2021-07